Pharmacosmos is looking to fill a vacant position as International Medical Director to excel in the cross field between Science and Marketing & Sales. The International Medical Director has the overall responsibility to ensure a liaison between Medical and Regulatory, Clinical R & D, Marketing and Sales. To act as medical advisor towards partners and own sales organisation concerning scientific documentation, competitive intelligence, medical and product education, medical enquires and study proposals. Further to interact with KOL’s locally, investigators, professional associations and government institutions with purpose of strengthening the relations with and the knowledge about Pharmacosmos and their products and support the medical strategy and activities in the country.
You will be working in a cross-functional team in an international environment, where team spirit, willingness to contribute, high energy and optimism are rewarded with a fun working atmosphere, dedicated colleagues, good sparring and knowing that your contribution matters.
The International Medical Director reports to the Head of Global Medical Affairs.
The workplace is in Holbæk.
Medical & therapeutic are knowledge
Professional experience of the ideal background:
Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.
Pharmacosmos has subsidiaries in US, China, UK, Ireland, Germany, Sweden and Norway and its products are marketed in more than 80 countries around the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.
Vi takker for din henvendelse og vender tilbage til dig hurtigst muligt
You are now leaving Pharmacosmos.com. The website you are about to visit is a Pharmacosmos subsidary.
Do you wish to proceed?